ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET
Globe Newswire•23/10/2026•06:55 ET
0
Key Highlights
- ➤ANI Pharmaceuticals will release third-quarter 2026 results November 5, 2026, at 8:00 a.m. ET
- ➤Nikhil Lalwani, Stephen P. Carey, and Chris Mutz will host the earnings webcast
- ➤ANI’s business spans Rare Disease, Generics, and Brands segments
PRINCETON, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its third quarter 2026 financial results on Thursday, November 5, 2026, at 8:00 a.m. ET.
Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, and Chris Mutz, Head of Rare Disease will host a webcast and conference call to discuss the results.
Get started
Create a free account to read the full story.